Glycomics is the study of carbohydrates and carbohydrate-containing biomolecules in biological processes such as cell recognition, immune response, cell-to-cell interaction, infection and inflammation. These processes are dependent on the intricate glycan structures present on interacting biomolecules. Advanced technologies such as high-throughput mass spectroscopy, glycan microarrays, and carbohydrate chemistry are helping to unravel the complexity resulting from this diversity.

This report segment the global glycomics market by application, end users, products, and geographies. The application segments included in this report are diagnostics; drug discovery and development; immunology; oncology; and other applications. The end-user segments of this market are academic research institutes, contract research organizations, and pharmaceutical and biotechnology companies. The product segments included in this report are enzymes; instruments; kits; and reagents. Glycosidases; glycosyltransferases; neuraminidases; sialyltransferases; and other enzymes are subsegments of the enzymes product segment. Antibody arrays; HPLC; lectin arrays; MALDI-TOF; mass spectrometers; and other glycomics instruments are subsegments of the instruments product segment. Glycan labeling kits; glycan purification kits; glycan release kits; and other glycomics kits are subsegments of the kits market. Glycoproteins; monosaccharaides; oligosaccharides; and other glycomics reagents are subsegments of the reagents product segment.

The geographic segments included in this report are Asia, Europe, North America and Rest of the World (RoW). Asia is further divided into the regional segments of China, India, Japan, and Rest of Asia. Europe is divided into the regional segments of France, Germany, Italy, Spain, the U.K., and the Rest of Europe. North America includes Canada, and the U.S. RoW encompasses the Middle East and Africa, Pacific and Oceania, and South America.

The key drivers for this market are the rising R&D expenditure by pharmaceutical and biotech companies, and increasing public and private funding for proteomics and glycomics research. According to the World Bank, funding for research and development activities in Asia was about $158.94 billion in 2001 and increased to $329.31 billion in 2010. Similarly, in the U.S., overall funding for research and development was about $291.77 billion in 2001, which increased to $428.94 billion in 2010. Increased funding activities are expected to positively impact the growth of the glycomics enzymes, instruments, kits, and reagents market.

A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global glycomics enzymes, instruments, kits, and reagents market and its subsegments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their glycomics enzymes, instruments, kits and reagents market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights on key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised to see rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the glycomics enzymes, instruments, kits and reagents market. The competitive landscape covers the growth strategies adopted by industry players over the last three years. It also includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:

• Product Development/Innovation: Product portfolios of top players in the glycomics enzymes, instruments, kits and reagents market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the glycomics market
• Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of leading players in the glycomics market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various glycomics enzymes, instruments, kits and reagents products across geographies
• Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the glycomics enzymes, instruments, kits and reagents market

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Markets Covered
1.3 Stakeholders
1.4 Market Scope

2 Research Methodology
2.1 Description of the Glycomics Demand Model
2.1.1 Growth in R&D Expenditure
2.1.2 Increasing Number of Biotechnology Patents
2.2 Market Size Estimation
2.3 Market Crackdown and Data Triangulation
2.4 Market Share Estimation
2.4.1 Key Data From Secondary Sources
2.4.2 Key Data From Primary Sources
2.4.2.1 Key Industry Insights
2.4.3 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Lucrative Opportunities in the Global Glycomics Market
4.2 Life Cycle Analysis, By Geography

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 Glycomics Market, By Product
5.2.2 Glycomics Market, By Application
5.2.3 Glycomics Market, By End User
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing Government and Private Funding for Proteomics and Glycomics Research
5.3.1.2 Increasing Pharmaceutical and Biotechnology R&D Expenditure
5.3.1.3 Growing Proteomics Market
5.3.1.4 Technological Advancements for Glycomics Research
5.3.2 Restraints
5.3.2.1 High Degree of Consolidation Acts As An Entry Barrier for New Entrants
5.3.3 Opportunities
5.3.3.1 Increased Use of Personalized Medicine
5.3.3.2 Developing Countries Present Significant Opportunities for the Glycomics Market
5.3.4 Challenges
5.3.4.1 Stringent Regulatory Frameworks Act As A Major Challenge

6 Industry Insights
6.1 Introduction
6.2 Value Chain Analysis
6.3 Supply Chain Analysis
6.3.1 Key Influencers
6.4 Porter’s Five forces Analysis
6.4.1 Threat From New Entrants
6.4.2 Threat From Substitutes
6.4.3 Bargaining Power of Buyers
6.4.4 Bargaining Power of Suppliers
6.4.5 Intensity of Rivalry
6.5 Strategic Benchmarking
6.5.1 New Product Launches

7 Glycomics Market, By Product
7.1 Introduction
7.2 Enzymes
7.2.1 Glycosidases
7.2.2 Glycosyltransferases
7.2.3 Neuraminidases
7.2.4 Sialyltransferases
7.2.5 Other Enzymes
7.3 Instruments
7.3.1 Antibody Arrays
7.3.2 HPLC
7.3.3 Lectin Arrays
7.3.4 Maldi-TOF
7.3.5 Mass Spectrometry
7.3.6 Other Instruments
7.4 Kits
7.4.1 Glycan Labeling Kits
7.4.2 Glycan Purification Kits
7.4.3 Glycan Release Kits
7.4.4 Other Kits
7.5 Reagents
7.5.1 Glycoproteins
7.5.2 Monosaccharides
7.5.3 Oligosaccharides
7.5.4 Other Reagents

8 Glycomics Market, By Application
8.1 Introduction
8.2 Diagnostics
8.3 Drug Discovery & Development
8.4 Immunology
8.5 Oncology
8.6 Other Applications

9 Glycomics Market, By End User
9.1 Introduction
9.2 Academic Research Insitutes
9.3 Contract Research Organizations
9.4 Pharmaceutical & Biotechnology Companies

10 Geographic Analysis
10.1 Introduction
10.2 Asia
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 Rest of Asia
10.3 Europe
10.3.1 France
10.3.2 Germany
10.3.3 Italy
10.3.4 Spain
10.3.5 U.K.
10.3.6 Roe
10.4 North America
10.4.1 Canada
10.4.2 U.S.
10.5 ROW
10.5.1 Middle East and Africa
10.5.2 Pacific and Oceania
10.5.3 South America

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, Glycomics Enzymes, Kits, and Regents Market
11.3 Market Share Analysis, Glycomics Instruments Market
11.4 Competitive Situation and Trends
11.4.1 New Product Launches
11.4.2 Agreements, Partnerships, and Collaborations
11.4.3 Acquisitions
11.4.4 Expansions
11.4.5 Other Developments

12 Company Profiles
12.1 Introduction
12.2 Bruker Corporation
12.3 New England Biolabs
12.4 Shimadzu Corporation
12.5 Sigma-Aldrich Corporation
12.6 Takara Bio
12.7 Waters Corporation
12.8 Agilent Technologies, Inc.
12.9 Danaher Corporation
12.10 Prozyme
12.11 Thermo Fisher Scientific

13 Appendix
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Introducing Rt: Real Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports

List of Tables

Table 1 Glycomics Market Size, By Product, 2012–2019 ($Million)
Table 2 Glycomics Enzymes Market, By Product, 2012–2019 ($Million)
Table 3 Glycomics Enzymes Market, By Geography, 2012–2019 ($Million)
Table 4 Glycosidases Enzymes Market, By Geography, 2012–2019 ($Million)
Table 5 Glycosyltransferases Enzymes Market, By Geography, 2012–2019 ($Million)
Table 6 Neuraminidases Enzymes Market, By Geography, 2012–2019 ($Million)
Table 7 SialyltransferasesEnzymes Market, By Geography, 2012–2019 ($Million)
Table 8 Other GlycomicsEnzymes Market, By Geography, 2012–2019 ($Million)
Table 9 Glycomics Instruments Market, By Product, 2012–2019 ($Million)
Table 10 Glycomics Instruments Market, By Geography, 2012–2019 ($Million)
Table 11 Antibody Arrays Instruments Market, By Geography, 2012–2019 ($Million)
Table 12 HPLC Instruments Market, By Geography, 2012–2019 ($Million)
Table 13 Lectin Arrays Instruments Market, By Geography, 2012–2019 ($Million)
Table 14 Maldi-TOF Instruments Market, By Geography, 2012–2019 ($Million)
Table 15 Mass Spectrometry Instruments Market, By Geography, 2012–2019 ($Million)
Table 16 Other Glycomics Instruments Market, By Geography, 2012–2019 ($Million)
Table 17 Glycomics Kits Market, By Product, 2012–2019 ($Million)
Table 18 Glycomics Kits Market, By Geography, 2012–2019 ($Million)
Table 19 Glycan Labeling Kits Market, By Geography, 2012–2019 ($Million)
Table 20 Glycan Purification Kits Market, By Geography, 2012–2019 ($Million)
Table 21 Glycan Release Kits Market, By Geography, 2012–2019 ($Million)
Table 22 Other Glycomics Kits Market, By Geography, 2012–2019 ($Million)
Table 23 Glycomics Reagents Market, By Product, 2012–2019 ($Million)
Table 24 Glycomics Reagents Market, By Geography, 2012–2019 ($Million)
Table 25 Glycoproteins Reagents Market, By Geography, 2012–2019 ($Million)
Table 26 Monosaccharides Reagents Market, By Geography, 2012–2019 ($Million)
Table 27 Oligosaccharides Reagents Market, By Geography, 2012–2019 ($Million)
Table 28 Other Glycomics Reagents Market, By Geography, 2012–2019 ($Million)
Table 29 Glycomics Market Size, By Application, 2012–2019 ($Million)
Table 30 Glycobiology Market Size for Diagnostics, By Region, 2012–2019 ($Million)
Table 31 Glycomics Market Size for Drug Discovery and Development, By Region, 2012–2019 ($Million)
Table 32 Market Size for Immunology, By Geography, 2012–2019 ($Million)
Table 33 Market Size for Oncology, By Geography, 2012–2019 ($Million)
Table 34 Market Size for Other Applications, By Geography, 2012–2019 ($Million)
Table 35 Market Size, By End User, 2012–2019 ($Million)
Table 36 Market Size for Academic Research Institutes, By Geography, 2012–2019 ($Million)
Table 37 Market Size for Contract Research Organizations, By Geography, 2012–2019 ($Million)
Table 38 Market Size for Pharmaceutical & Biotechnology Companies, By Geography, 2012–2019 ($Million)
Table 39 Glycomics Market, By Geography, 2012–2019 ($Million)
Table 40 Asia: Glycomics Market, By Geography, 2012–2019 ($Million)
Table 41 Asia: Market, By End User, 2012–2019 ($Million)
Table 42 Asia: Glycomics Market, By Product, 2012–2019 ($Million)
Table 43 Asia: Glycobiology Enzymes Market, ByType, 2012–2019 ($Million)
Table 44 Asia: Glycomics Instruments Market, By Type, 2012–2019 ($Million)
Table 45 Asia: Glycomics Kits Market, By Type, 2012–2019 ($Million)
Table 46 Asia: Glycomics Reagents Market, By Type, 2012–2019 ($Million)
Table 47 Asia: Glycobiology Market, By Application, 2012–2019 ($Million)
Table 48 Europe: Glycomics Market, By Geography, 2012–2019 ($Million)
Table 49 Europe: Glycobiology Market, By End User, 2012–2019 ($Million)
Table 50 Europe: Glycomics Market, By Product, 2012–2019 ($Million)
Table 51 Europe: Glycomics Enzymes Market, ByType, 2012–2019 ($Million)
Table 52 Europe: Glycobiology Instruments Market, By Type, 2012–2019 ($Million)
Table 53 Europe: Glycomics Kits Market, By Type, 2012–2019 ($Million)
Table 54 Europe: Glycomics Reagents Market, By Type, 2012–2019 ($Million)
Table 55 Europe: Market, By Application, 2012–2019 ($Million)
Table 56 North America: Glycomics Market, By Geography, 2012–2019 ($Million)
Table 57 North America: Glycomics Market, By End User, 2012–2019 ($Million)
Table 58 North America: Glycobiology Market, By Product, 2012–2019 ($Million)
Table 59 North America: Glycomics Enzymes Market, ByType, 2012–2019 ($Million)
Table 60 North America: Glycomics Instruments Market, By Type, 2012–2019 ($Million)
Table 61 North America: Glycomics Kits Market, By Type, 2012–2019 ($Million)
Table 62 North America: Glycomics Reagents Market, By Type, 2012–2019 ($Million)
Table 63 North America: Market, By Application, 2012–2019 ($Million)
Table 64 ROW: Glycomics Market, By Geography, 2012–2019 ($Million)
Table 65 ROW: Glycomics Market, By End User, 2012–2019 ($Million)
Table 66 ROW: Glycobiology Market, By Product, 2012–2019 ($Million)
Table 67 ROW: Glycomics Enzymes Market, ByType, 2012–2019 ($Million)
Table 68 ROW: Glycomics Instruments Market, By Type, 2012–2019 ($Million)
Table 69 ROW: Glycobiology Kits Market, By Type, 2012–2019 ($Million)
Table 70 ROW: Glycomics Reagents Market, By Type, 2012–2019 ($Million)
Table 71 ROW: Market, By Application, 2012–2019 ($Million)
Table 72 New Product Launches, 2011–2014
Table 73 Agreements, Collaborations, and Partnerships, 2011–2014
Table 74 Acquisitions, 2011–2014
Table 75 Expansions, 2011–2014
Table 76 Other Developments, 2012–2013

List of Figures

Figure 1 Research Methodology
Figure 2 Increased R&D Expenditure on Glycomics Will Drive the Global Market
Figure 3 Increasing Number of Biotechnology Patents Reflect the Increased Research in the Glycomics Market
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Break Down of Primary Interviews: By Company Type, Designation, & Region
Figure 7 Enzymes Are Expected to Be the Fastest-Growing Product Segment in the forecast Period
Figure 8 Glycosidases Has the Largest Share of the Glycobiology Enzymes Market
Figure 9 Mass Spectrometry is Expected to Grow At the Highest Rate in the forecast Period
Figure 10 Glycan Release Kits to Dominate the Glycomics Kits Market
Figure 11 Oligosaccharides Command the Largest Share of the Glycomics Reagents Market
Figure 12 Increasing Funding in Glycobiology and Proteomics Research Will Drive the North American Glycomics Market
Figure 13 Attractive Opportunities in Market
Figure 14 Glycomics Enzymes to Account for Largest Market Share (2014)
Figure 15 North America to Account for Largest Share of the Global Glycomics Market (2014)
Figure 16 Asia Holds Lucrative Growth Opportunities
Figure 17 Glycomics Market Segmentation, By Product
Figure 18 Glycobiology Market Segmentation, By Application
Figure 19 Glycobiology Market Segmentation, By End User
Figure 20 Increasing Government and Private Funding for Proteomics and Glycomics Research Will Spur the Demand for Glycomics Products
Figure 21 Value Chain Analysis (2014): Major Value is Added During Manufacturing and Assembly Phase
Figure 22 Supply Chain: Direct Distribution is the Most Prefered Strategy Followed By Prominent Companies
Figure 23 Porter’s Five forces Analysis – High Capital Investment for R&D and Manufacturing Glycommics Products Will Restrict the Entry of New Player
Figure 24 Strategic Bench Marking: All Market Leaders Adopted Organic Growth Strtaegies of New Product Launches
Figure 25 Market Segmentation, By Product
Figure 26 Market Size, By Product, 2014 (Market Size and Growth Rates)
Figure 27 Glycomic Enzymes Market, By Products
Figure 28 Glycosidases Enzymes Will Be the Fastest Growing Segment in Glycomics Enzymes Market
Figure 29 North America Commands the Largest Share in Glycosidases Enzymes Market
Figure 30 North America Commands the Largest Share in Glycosyltransferases Enzymes Market
Figure 31 North America Commands the Largest Share in Neuraminidases Enzymes Market
Figure 32 North America Commands the Largest Share in Sialyltransferases Enzymes Market
Figure 33 North America Commands the Largest Share in Other Glycobiology Enzymes Market
Figure 34 Glycomic Instruments Market, By Products
Figure 35 Mass Spectrometry Instruments Will Be the Fastest Growing Segment in Glycobiology Instruments Market
Figure 36 North America Commands the Largest Share in Antibody Arrays Instruments Market
Figure 37 North America Commands the Largest Share in HPLC Instruments Market
Figure 38 North America Commands the Largest Share in Lectin Arrays Instruments Market
Figure 39 North America Commands the Largest Share in Maldi-TOF Instruments Market
Figure 40 North America Commands the Largest Share in Mass Spectrometery Instruments Market
Figure 41 North America Commands the Largest Share in Mass Spectrometery Instruments Market
Figure 42 Glycomic Kits Market, By Products
Figure 43 Glycan Release Kits Will Be the Fastest Growing Segment in Glycomics Kits Market
Figure 44 North America Commands the Largest Share in Glycan Labeling Kits Market
Figure 45 North America Commands the Largest Share in Glycan Purification Kits Market
Figure 46 North America Commands the Largest Share in Glycan Release Kits Market
Figure 47 North America Commands the Largest Share in Other Glycobiology Kits Market
Figure 48 Glycomic Reagents Market, By Products
Figure 49 Oligosaccharides Reagents Will Be the Fastest Growing Segment in Glycomics Reagents Market
Figure 50 North America Commands the Largest Share in Glycoproteins Reagents Market
Figure 51 North America Commands the Largest Share in Monosaccharides Reagents Market
Figure 52 North America Commands the Largest Share in Oligosaccharides Reagents Market
Figure 53 Europe Commands the Largest Share in Other Glycobiology Reagents Market
Figure 54 Glycomics Market Segmentation, By Application
Figure 55 Global Glycomics Market, By Application, 2014 (Market Size & Growth Rate)
Figure 56 Drug Discovery & Development Will Be the Fastest-Growing Application Segment of the Glycomics Market
Figure 57 North America to Command the Largest Share of the Diagnostics Segment
Figure 58 North America Commands the Largest Share in the Drug Discovery & Development Application Segment
Figure 59 Increase Research Application of Epigenetics in Immunology to Aid the Growth of This Application Segment
Figure 60 North America Commands the Largest Share in Immunology Owing to Increased Research Activities
Figure 61 North America to Command the Largest Share in Oncology Due to High Degree of Funding in Cancer Research in This Region
Figure 62 Europe Commands the Largest Share in the Other Applications Segment
Figure 63 Market Segmentation, By End User
Figure 64 Glycomics Market Size, By End User, 2014 (Market Size & Growth Rates)
Figure 65 Academic Research Institutes Will Be the Fastest-Growing End-User Segment
Figure 66 North America Will Be the Fastest-Growing Geographic Segment Due to Increased Funding for Glycobiology Research
Figure 67 Europe Will Be the Fastest-Growing Geographic Segment Due to Increasing Partnerships Between Research Institutes and Biotechnology Companies
Figure 68 Europe Will Be the Fastest-Growing Segment Due to Increased Outsourcing of Drug Discovery Research Activities to This Region
Figure 69 Geographic Snapshot (2014)
Figure 70 Asia Market Snapshot
Figure 71 Asia: Glycomics Market – By Product
Figure 72 Asia: Glycomics Market – By Product
Figure 73 China: Glycomics Market – By Product
Figure 74 India: Glycomics Market – By Product
Figure 75 Japan: Glycomics Market – By Product
Figure 76 Roa: Glycomics Market – By Product
Figure 77 Europe Market Snapshot
Figure 78 Europe: Glycomics Market – By Product
Figure 79 Europe: Glycomics Market – By Product
Figure 80 France: Glycomics Market – By Product
Figure 81 Germany: Glycomics Market – By Product
Figure 82 Italy: Glycomics Market – By Product
Figure 83 Spain: Glycomics Market – By Product
Figure 84 U.K.: Glycomics Market – By Product
Figure 85 Roe: Glycomics Market – By Product
Figure 86 North America Market Snapshot
Figure 87 North America: Glycomics Market – By Product
Figure 88 North America: Glycomics Market – By Product
Figure 89 Canada: Glycomics Market – By Product
Figure 90 U.S.: Glycomics Market – By Product
Figure 91 ROW Market Snapshot
Figure 92 ROW: Glycobiology Market – By Product
Figure 93 ROW: Glycomics Market – By Product
Figure 94 Middle East Nad Africa: Glycobiology Market – By Product
Figure 95 Pacific and Oceania: Glycomics – By Product
Figure 96 South America: Glycomics Market – By Product
Figure 97 Companies Adopted New Product Launches As A Key Growth Strategy
Figure 98 Global Glycomics Enzymes, Kits and Reagents (Excluding Instruments) Market Share Analysis, By Key Player, 2014
Figure 99 Global Glycomics Instruments Market Share Analysis, By Key Player, 2014
Figure 100 Battle for Market Share: New Product Launches Was the Key Strategy
Figure 101 Geographic Revenue Mix of Top 5 Market Players
Figure 102 Company Snapshot
Figure 103 SWOT Analysis
Figure 104 SWOT Analysis
Figure 105 Company Snapshot
Figure 106 SWOT Analysis
Figure 107 Company Snapshot
Figure 108 SWOT Analysis
Figure 109 Company Snapshot
Figure 110 SWOT Analysis
Figure 111 Company Snapshot
Figure 112 SWOT Analysis
Figure 113 Company Snapshot
Figure 114 Company Snapshot
Figure 115 Company Snapshot